|Should I start treatment
Dec 23, 2006
In Sept. 06 I found out I have HIV. I have had two test done - (1st) 363 cd4 and viral greater than 100,000 (2nd) 452 cd4 and viral greater than 100,000. I am 48. My doctor has recommended Atripla. Should I wait to start? What are the advantages and disadvantages of starting early? Should I consider another medication? I am heavy set about 305 - What impact will the medicine have?
Response from Dr. Pierone
Hello, and thanks for posting.
The advantage of starting early is that unchecked HIV infection is not a good thing and may result in a loss of immune function which may not reconstitute later on when therapy is commenced. There is also a lower risk of transmitting HIV to an intimate partner in the case of a condom failure.
Atripla is a very attractive starting medication since it is one pill, once a day. It has been shown to be very effective and is the standard to beat for any new frontline HIV regimen. Many people experience neuro-cognitive side effects from the Sustiva component dizziness, fuzzy-headed sensations, sleepiness, are examples. These side effects usually go away within weeks to several months. But some people never get over it, or develop a worsening of depression and need to change to something else.
It is highly effective and the expectation would be for your viral load to become undetectable and the CD4+ lymphocyte count to progressively improve.
Best of luck to you and let us know how things go.
Long acting meds in the pipeline?
IS IT TIME TO START?
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.